nodes	percent_of_prediction	percent_of_DWPC	metapath
Scopolamine—CHRM1—Circadian rythm related genes—MC3R—salivary gland cancer	0.00728	0.00728	CbGpPWpGaD
Scopolamine—CHRM5—Class A/1 (Rhodopsin-like receptors)—MC3R—salivary gland cancer	0.00726	0.00726	CbGpPWpGaD
Scopolamine—SI—Disease—NUP62—salivary gland cancer	0.00718	0.00718	CbGpPWpGaD
Scopolamine—SI—Disease—VCAN—salivary gland cancer	0.00712	0.00712	CbGpPWpGaD
Scopolamine—CHRM5—Regulation of Actin Cytoskeleton—FGFR4—salivary gland cancer	0.00702	0.00702	CbGpPWpGaD
Scopolamine—CHRM1—Regulation of Actin Cytoskeleton—FGF16—salivary gland cancer	0.00669	0.00669	CbGpPWpGaD
Scopolamine—CHRM3—Regulation of Actin Cytoskeleton—FGF16—salivary gland cancer	0.00667	0.00667	CbGpPWpGaD
Scopolamine—CHRM2—Regulation of Actin Cytoskeleton—FGF16—salivary gland cancer	0.0066	0.0066	CbGpPWpGaD
Scopolamine—SI—Disease—MAML2—salivary gland cancer	0.0065	0.0065	CbGpPWpGaD
Scopolamine—CHRM2—SIDS Susceptibility Pathways—MYB—salivary gland cancer	0.00642	0.00642	CbGpPWpGaD
Scopolamine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FOXO3—salivary gland cancer	0.00631	0.00631	CbGpPWpGaD
Scopolamine—SI—Metabolism—NUP62—salivary gland cancer	0.00601	0.00601	CbGpPWpGaD
Scopolamine—SI—Metabolism—VCAN—salivary gland cancer	0.00596	0.00596	CbGpPWpGaD
Scopolamine—CHRM1—GPCRs, Class A Rhodopsin-like—MC3R—salivary gland cancer	0.00596	0.00596	CbGpPWpGaD
Scopolamine—CHRM3—GPCRs, Class A Rhodopsin-like—MC3R—salivary gland cancer	0.00594	0.00594	CbGpPWpGaD
Scopolamine—CHRM2—GPCRs, Class A Rhodopsin-like—MC3R—salivary gland cancer	0.00589	0.00589	CbGpPWpGaD
Scopolamine—CHRM4—GPCR ligand binding—MC3R—salivary gland cancer	0.00577	0.00577	CbGpPWpGaD
Scopolamine—SI—Disease—JAG1—salivary gland cancer	0.00555	0.00555	CbGpPWpGaD
Scopolamine—SI—Disease—FGFR4—salivary gland cancer	0.00553	0.00553	CbGpPWpGaD
Scopolamine—CHRM5—GPCR ligand binding—MC3R—salivary gland cancer	0.00553	0.00553	CbGpPWpGaD
Scopolamine—CHRM1—Circadian rythm related genes—PRKDC—salivary gland cancer	0.00552	0.00552	CbGpPWpGaD
Scopolamine—SI—Disease—FBXW7—salivary gland cancer	0.00544	0.00544	CbGpPWpGaD
Scopolamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—MC3R—salivary gland cancer	0.00511	0.00511	CbGpPWpGaD
Scopolamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—MC3R—salivary gland cancer	0.00509	0.00509	CbGpPWpGaD
Scopolamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—MC3R—salivary gland cancer	0.00504	0.00504	CbGpPWpGaD
Scopolamine—CHRM4—Regulation of Actin Cytoskeleton—MAP2K2—salivary gland cancer	0.00496	0.00496	CbGpPWpGaD
Scopolamine—CHRM1—Regulation of Actin Cytoskeleton—FGFR4—salivary gland cancer	0.00494	0.00494	CbGpPWpGaD
Scopolamine—CHRM3—Regulation of Actin Cytoskeleton—FGFR4—salivary gland cancer	0.00492	0.00492	CbGpPWpGaD
Scopolamine—CHRM2—Regulation of Actin Cytoskeleton—FGFR4—salivary gland cancer	0.00488	0.00488	CbGpPWpGaD
Scopolamine—CHRM5—Regulation of Actin Cytoskeleton—MAP2K2—salivary gland cancer	0.00475	0.00475	CbGpPWpGaD
Scopolamine—SI—Disease—FOXO3—salivary gland cancer	0.00459	0.00459	CbGpPWpGaD
Scopolamine—CHRM1—Circadian rythm related genes—TOP2A—salivary gland cancer	0.00418	0.00418	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—MC3R—salivary gland cancer	0.00389	0.00389	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—MC3R—salivary gland cancer	0.00388	0.00388	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—MC3R—salivary gland cancer	0.00384	0.00384	CbGpPWpGaD
Scopolamine—SI—Disease—MAP2K2—salivary gland cancer	0.00375	0.00375	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.00363	0.00363	CbGpPWpGaD
Scopolamine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—MAP2K2—salivary gland cancer	0.00355	0.00355	CbGpPWpGaD
Scopolamine—CHRM1—Regulation of Actin Cytoskeleton—MAP2K2—salivary gland cancer	0.00335	0.00335	CbGpPWpGaD
Scopolamine—CHRM3—Regulation of Actin Cytoskeleton—MAP2K2—salivary gland cancer	0.00334	0.00334	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—ERBB2IP—salivary gland cancer	0.00333	0.00333	CbGpPWpGaD
Scopolamine—CHRM2—Regulation of Actin Cytoskeleton—MAP2K2—salivary gland cancer	0.0033	0.0033	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—MC3R—salivary gland cancer	0.00326	0.00326	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—ERBB2IP—salivary gland cancer	0.00319	0.00319	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—MC3R—salivary gland cancer	0.00312	0.00312	CbGpPWpGaD
Scopolamine—SI—Disease—NOTCH1—salivary gland cancer	0.00307	0.00307	CbGpPWpGaD
Scopolamine—ABCB1—HIF-1-alpha transcription factor network—CREBBP—salivary gland cancer	0.00302	0.00302	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—MC3R—salivary gland cancer	0.00296	0.00296	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—MC3R—salivary gland cancer	0.00284	0.00284	CbGpPWpGaD
Scopolamine—SI—Disease—CREBBP—salivary gland cancer	0.00278	0.00278	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—salivary gland cancer	0.00276	0.00276	CbGpPWpGaD
Scopolamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—MAP2K2—salivary gland cancer	0.0025	0.0025	CbGpPWpGaD
Scopolamine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—MAP2K2—salivary gland cancer	0.00249	0.00249	CbGpPWpGaD
Scopolamine—CHRM2—SIDS Susceptibility Pathways—CREBBP—salivary gland cancer	0.00237	0.00237	CbGpPWpGaD
Scopolamine—SI—Metabolism—CREBBP—salivary gland cancer	0.00233	0.00233	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—ISYNA1—salivary gland cancer	0.00228	0.00228	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—ERBB2IP—salivary gland cancer	0.00225	0.00225	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—ERBB2IP—salivary gland cancer	0.00224	0.00224	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—WNT5B—salivary gland cancer	0.00222	0.00222	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—ERBB2IP—salivary gland cancer	0.00222	0.00222	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—salivary gland cancer	0.0022	0.0022	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—MC3R—salivary gland cancer	0.0022	0.0022	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—MC3R—salivary gland cancer	0.00219	0.00219	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—MC3R—salivary gland cancer	0.00217	0.00217	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—IL17RD—salivary gland cancer	0.00215	0.00215	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—WNT5B—salivary gland cancer	0.00213	0.00213	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—IL17RD—salivary gland cancer	0.00205	0.00205	CbGpPWpGaD
Scopolamine—ABCB1—HIF-1-alpha transcription factor network—EP300—salivary gland cancer	0.00205	0.00205	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—MC3R—salivary gland cancer	0.002	0.002	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—MC3R—salivary gland cancer	0.00199	0.00199	CbGpPWpGaD
Scopolamine—SI—Disease—PTEN—salivary gland cancer	0.00199	0.00199	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—MC3R—salivary gland cancer	0.00197	0.00197	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—MAML3—salivary gland cancer	0.00196	0.00196	CbGpPWpGaD
Scopolamine—SI—Disease—EP300—salivary gland cancer	0.0019	0.0019	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—MAML3—salivary gland cancer	0.00188	0.00188	CbGpPWpGaD
Scopolamine—CHRM4—Regulation of Actin Cytoskeleton—PIK3CA—salivary gland cancer	0.00186	0.00186	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—MARCKS—salivary gland cancer	0.00186	0.00186	CbGpPWpGaD
Scopolamine—CHRM5—Regulation of Actin Cytoskeleton—PIK3CA—salivary gland cancer	0.00178	0.00178	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—MC3R—salivary gland cancer	0.00175	0.00175	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PYGB—salivary gland cancer	0.00172	0.00172	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—ST3GAL4—salivary gland cancer	0.00168	0.00168	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—MC3R—salivary gland cancer	0.00168	0.00168	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.00166	0.00166	CbGpPWpGaD
Scopolamine—SI—Metabolism—PTEN—salivary gland cancer	0.00166	0.00166	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—ST3GAL4—salivary gland cancer	0.00161	0.00161	CbGpPWpGaD
Scopolamine—CHRM2—SIDS Susceptibility Pathways—EP300—salivary gland cancer	0.00161	0.00161	CbGpPWpGaD
Scopolamine—SI—Metabolism—EP300—salivary gland cancer	0.00159	0.00159	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—DTX4—salivary gland cancer	0.00153	0.00153	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—WNT5B—salivary gland cancer	0.0015	0.0015	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—WNT5B—salivary gland cancer	0.00149	0.00149	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—salivary gland cancer	0.00148	0.00148	CbGpPWpGaD
Scopolamine—CHRM5—G alpha (q) signalling events—PIK3CA—salivary gland cancer	0.00148	0.00148	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—WNT5B—salivary gland cancer	0.00148	0.00148	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—DTX4—salivary gland cancer	0.00146	0.00146	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—IL17RD—salivary gland cancer	0.00145	0.00145	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—ISYNA1—salivary gland cancer	0.00144	0.00144	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—IL17RD—salivary gland cancer	0.00144	0.00144	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—IL17RD—salivary gland cancer	0.00143	0.00143	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PHGDH—salivary gland cancer	0.00141	0.00141	CbGpPWpGaD
Scopolamine—SI—Disease—PIK3CA—salivary gland cancer	0.0014	0.0014	CbGpPWpGaD
Scopolamine—CHRM1—Circadian rythm related genes—PTEN—salivary gland cancer	0.0014	0.0014	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—ST3GAL4—salivary gland cancer	0.00135	0.00135	CbGpPWpGaD
Scopolamine—CHRM1—Circadian rythm related genes—EP300—salivary gland cancer	0.00133	0.00133	CbGpPWpGaD
Scopolamine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—salivary gland cancer	0.00133	0.00133	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—MAML3—salivary gland cancer	0.00132	0.00132	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.00132	0.00132	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—MAML3—salivary gland cancer	0.00132	0.00132	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—MAML3—salivary gland cancer	0.00131	0.00131	CbGpPWpGaD
Scopolamine—SI—Disease—HRAS—salivary gland cancer	0.0013	0.0013	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—salivary gland cancer	0.00129	0.00129	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—FGF16—salivary gland cancer	0.00126	0.00126	CbGpPWpGaD
Scopolamine—CHRM1—Regulation of Actin Cytoskeleton—PIK3CA—salivary gland cancer	0.00125	0.00125	CbGpPWpGaD
Scopolamine—CHRM3—Regulation of Actin Cytoskeleton—PIK3CA—salivary gland cancer	0.00125	0.00125	CbGpPWpGaD
Scopolamine—CHRM2—Regulation of Actin Cytoskeleton—PIK3CA—salivary gland cancer	0.00124	0.00124	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—AQP1—salivary gland cancer	0.00123	0.00123	CbGpPWpGaD
Scopolamine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—salivary gland cancer	0.00123	0.00123	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—FGF16—salivary gland cancer	0.00121	0.00121	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—MC3R—salivary gland cancer	0.00118	0.00118	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—MARCKS—salivary gland cancer	0.00118	0.00118	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—MC3R—salivary gland cancer	0.00118	0.00118	CbGpPWpGaD
Scopolamine—SI—Metabolism—PIK3CA—salivary gland cancer	0.00117	0.00117	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—MC3R—salivary gland cancer	0.00116	0.00116	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—ST3GAL4—salivary gland cancer	0.00114	0.00114	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—ST3GAL4—salivary gland cancer	0.00113	0.00113	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—ST3GAL4—salivary gland cancer	0.00112	0.00112	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—MAML2—salivary gland cancer	0.0011	0.0011	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PYGB—salivary gland cancer	0.00109	0.00109	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—MAP2K2—salivary gland cancer	0.00107	0.00107	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—MAML2—salivary gland cancer	0.00105	0.00105	CbGpPWpGaD
Scopolamine—CHRM1—G alpha (q) signalling events—PIK3CA—salivary gland cancer	0.00104	0.00104	CbGpPWpGaD
Scopolamine—CHRM3—G alpha (q) signalling events—PIK3CA—salivary gland cancer	0.00104	0.00104	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—DTX4—salivary gland cancer	0.00103	0.00103	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—DTX4—salivary gland cancer	0.00103	0.00103	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—MAP2K2—salivary gland cancer	0.00103	0.00103	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—DTX4—salivary gland cancer	0.00102	0.00102	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—NUP62—salivary gland cancer	0.000975	0.000975	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—VCAN—salivary gland cancer	0.000967	0.000967	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	0.000954	0.000954	CbGpPWpGaD
Scopolamine—CHRM1—Circadian rythm related genes—TP53—salivary gland cancer	0.000954	0.000954	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—JAG1—salivary gland cancer	0.000938	0.000938	CbGpPWpGaD
Scopolamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—salivary gland cancer	0.000934	0.000934	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—FGFR4—salivary gland cancer	0.000934	0.000934	CbGpPWpGaD
Scopolamine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—salivary gland cancer	0.000931	0.000931	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	0.000921	0.000921	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—FBXW7—salivary gland cancer	0.000919	0.000919	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—JAG1—salivary gland cancer	0.000898	0.000898	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—FGFR4—salivary gland cancer	0.000894	0.000894	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PHGDH—salivary gland cancer	0.000892	0.000892	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—FBXW7—salivary gland cancer	0.00088	0.00088	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	0.000878	0.000878	CbGpPWpGaD
Scopolamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—salivary gland cancer	0.000864	0.000864	CbGpPWpGaD
Scopolamine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—salivary gland cancer	0.000862	0.000862	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—ST3GAL4—salivary gland cancer	0.000859	0.000859	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—FGF16—salivary gland cancer	0.000853	0.000853	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—FGF16—salivary gland cancer	0.00085	0.00085	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—FGF16—salivary gland cancer	0.000842	0.000842	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—AQP1—salivary gland cancer	0.00078	0.00078	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—FOXO3—salivary gland cancer	0.000775	0.000775	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—FOXO3—salivary gland cancer	0.000742	0.000742	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—MAML2—salivary gland cancer	0.000741	0.000741	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—MAML2—salivary gland cancer	0.000738	0.000738	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—MAML2—salivary gland cancer	0.000731	0.000731	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—MAP2K2—salivary gland cancer	0.000722	0.000722	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—MAP2K2—salivary gland cancer	0.00072	0.00072	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—MAP2K2—salivary gland cancer	0.000713	0.000713	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	0.00065	0.00065	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—MAP2K2—salivary gland cancer	0.000633	0.000633	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—JAG1—salivary gland cancer	0.000632	0.000632	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—JAG1—salivary gland cancer	0.00063	0.00063	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—FGFR4—salivary gland cancer	0.00063	0.00063	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	0.000628	0.000628	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—FGFR4—salivary gland cancer	0.000628	0.000628	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—JAG1—salivary gland cancer	0.000624	0.000624	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—FGFR4—salivary gland cancer	0.000622	0.000622	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—FBXW7—salivary gland cancer	0.00062	0.00062	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—NUP62—salivary gland cancer	0.000618	0.000618	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—FBXW7—salivary gland cancer	0.000618	0.000618	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—VCAN—salivary gland cancer	0.000614	0.000614	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—FBXW7—salivary gland cancer	0.000612	0.000612	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—MAP2K2—salivary gland cancer	0.000606	0.000606	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—FOXO3—salivary gland cancer	0.000523	0.000523	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—FOXO3—salivary gland cancer	0.000521	0.000521	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—NOTCH1—salivary gland cancer	0.000519	0.000519	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—FOXO3—salivary gland cancer	0.000516	0.000516	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000512	0.000512	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—NOTCH1—salivary gland cancer	0.000497	0.000497	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CREBBP—salivary gland cancer	0.00047	0.00047	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CREBBP—salivary gland cancer	0.00045	0.00045	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000442	0.000442	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—MAP2K2—salivary gland cancer	0.000427	0.000427	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—MAP2K2—salivary gland cancer	0.000425	0.000425	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000423	0.000423	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—MAP2K2—salivary gland cancer	0.000421	0.000421	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000401	0.000401	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000384	0.000384	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—CREBBP—salivary gland cancer	0.000378	0.000378	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—HRAS—salivary gland cancer	0.000371	0.000371	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—HRAS—salivary gland cancer	0.000355	0.000355	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—NOTCH1—salivary gland cancer	0.00035	0.00035	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—NOTCH1—salivary gland cancer	0.000349	0.000349	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CCND1—salivary gland cancer	0.000348	0.000348	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—NOTCH1—salivary gland cancer	0.000345	0.000345	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—PTEN—salivary gland cancer	0.000336	0.000336	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CCND1—salivary gland cancer	0.000333	0.000333	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—PTEN—salivary gland cancer	0.000322	0.000322	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—EP300—salivary gland cancer	0.00032	0.00032	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CREBBP—salivary gland cancer	0.000317	0.000317	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CREBBP—salivary gland cancer	0.000316	0.000316	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CREBBP—salivary gland cancer	0.000313	0.000313	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—EP300—salivary gland cancer	0.000307	0.000307	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000298	0.000298	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000297	0.000297	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000294	0.000294	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—PIK3CA—salivary gland cancer	0.00027	0.00027	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PTEN—salivary gland cancer	0.00027	0.00027	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000269	0.000269	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000267	0.000267	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—EP300—salivary gland cancer	0.000257	0.000257	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—HRAS—salivary gland cancer	0.00025	0.00025	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—HRAS—salivary gland cancer	0.000249	0.000249	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—HRAS—salivary gland cancer	0.000247	0.000247	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CREBBP—salivary gland cancer	0.00024	0.00024	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—PIK3CA—salivary gland cancer	0.000237	0.000237	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CCND1—salivary gland cancer	0.000235	0.000235	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CCND1—salivary gland cancer	0.000234	0.000234	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CCND1—salivary gland cancer	0.000232	0.000232	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—TP53—salivary gland cancer	0.000229	0.000229	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—PIK3CA—salivary gland cancer	0.000227	0.000227	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PTEN—salivary gland cancer	0.000226	0.000226	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PTEN—salivary gland cancer	0.000226	0.000226	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PTEN—salivary gland cancer	0.000223	0.000223	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—TP53—salivary gland cancer	0.000219	0.000219	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—HRAS—salivary gland cancer	0.000219	0.000219	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—EP300—salivary gland cancer	0.000216	0.000216	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—EP300—salivary gland cancer	0.000215	0.000215	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—EP300—salivary gland cancer	0.000213	0.000213	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—HRAS—salivary gland cancer	0.00021	0.00021	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PIK3CA—salivary gland cancer	0.00019	0.00019	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PTEN—salivary gland cancer	0.000171	0.000171	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—EP300—salivary gland cancer	0.000163	0.000163	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PIK3CA—salivary gland cancer	0.00016	0.00016	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PIK3CA—salivary gland cancer	0.000159	0.000159	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PIK3CA—salivary gland cancer	0.000158	0.000158	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—TP53—salivary gland cancer	0.000155	0.000155	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—TP53—salivary gland cancer	0.000154	0.000154	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—TP53—salivary gland cancer	0.000153	0.000153	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—HRAS—salivary gland cancer	0.000148	0.000148	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—HRAS—salivary gland cancer	0.000147	0.000147	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—HRAS—salivary gland cancer	0.000146	0.000146	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PIK3CA—salivary gland cancer	0.000121	0.000121	CbGpPWpGaD
